IDT Biologika

Executive Summary

IDT Biologika is a premier global Contract Development and Manufacturing Organization (CDMO) with over a century of expertise in viral vaccines, gene and immune therapeutics, and aseptic fill-finish services. Based in Dessau-Roßlau, Germany, the company supports pharmaceutical and biotech clients from clinical development through commercial manufacturing, with a mission to accelerate the delivery of life-saving treatments worldwide. Its deep experience in sterile injectables and biologics positions it as a trusted partner in the rapidly growing CDMO market, driven by increasing demand for vaccine production and advanced therapies.

Upcoming Catalysts (preview)

• Q4 2026Expansion of commercial manufacturing capacity for viral vector-based therapies70% success
• Q2 2026Major contract win from a top-20 pharmaceutical company for vaccine production55% success
• Q1 2027Successful regulatory inspection for new aseptic fill-finish line80% success